Daiwabo Holdings Co., Ltd. (TYO:3107)
2,827.00
+42.00 (1.51%)
Aug 1, 2025, 3:30 PM JST
Intercept Pharmaceuticals Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 35,990 | 13,590 | 28,191 | 24,917 | 36,253 | Upgrade |
Depreciation & Amortization | 1,862 | 3,440 | 3,381 | 3,497 | 3,785 | Upgrade |
Loss (Gain) From Sale of Assets | -535 | 16,836 | 359 | 81 | -39 | Upgrade |
Loss (Gain) From Sale of Investments | - | -60 | -32 | -414 | - | Upgrade |
Loss (Gain) on Equity Investments | - | -43 | -96 | -22 | -13 | Upgrade |
Other Operating Activities | -6,969 | -10,010 | -4,889 | -12,706 | -9,218 | Upgrade |
Change in Accounts Receivable | -30,268 | -28,084 | -37,109 | 44,127 | -48,677 | Upgrade |
Change in Inventory | -12,491 | 2,225 | -1,305 | -3,728 | 494 | Upgrade |
Change in Accounts Payable | 19,828 | 27,696 | 33,369 | -30,125 | 30,816 | Upgrade |
Change in Other Net Operating Assets | -1,508 | -1,046 | -4,911 | 2,538 | -3,973 | Upgrade |
Operating Cash Flow | 5,909 | 24,544 | 16,958 | 28,165 | 9,428 | Upgrade |
Operating Cash Flow Growth | -75.92% | 44.73% | -39.79% | 198.74% | -49.00% | Upgrade |
Capital Expenditures | -1,925 | -2,018 | -1,653 | -2,715 | -2,757 | Upgrade |
Sale of Property, Plant & Equipment | 810 | 300 | 108 | 114 | 1,656 | Upgrade |
Cash Acquisitions | - | 2,003 | - | - | - | Upgrade |
Divestitures | - | -4,099 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -1,473 | -708 | -368 | -411 | -365 | Upgrade |
Investment in Securities | -3 | -430 | 16 | 179 | 79 | Upgrade |
Other Investing Activities | 3 | 6 | 269 | -93 | 30 | Upgrade |
Investing Cash Flow | -2,588 | -4,946 | -1,628 | -2,926 | -1,357 | Upgrade |
Short-Term Debt Issued | - | - | - | 911 | - | Upgrade |
Long-Term Debt Issued | 3,300 | 10,820 | 4,800 | 6,500 | 2,300 | Upgrade |
Total Debt Issued | 3,300 | 10,820 | 4,800 | 7,411 | 2,300 | Upgrade |
Short-Term Debt Repaid | - | -1,035 | -740 | - | -2,517 | Upgrade |
Long-Term Debt Repaid | -3,497 | -6,474 | -5,534 | -7,312 | -4,059 | Upgrade |
Total Debt Repaid | -3,497 | -7,509 | -6,274 | -7,312 | -6,576 | Upgrade |
Net Debt Issued (Repaid) | -197 | 3,311 | -1,474 | 99 | -4,276 | Upgrade |
Repurchase of Common Stock | -9,955 | 4 | -3,000 | -2,000 | -6 | Upgrade |
Dividends Paid | -7,067 | -5,971 | -5,649 | -8,593 | -3,072 | Upgrade |
Other Financing Activities | -183 | -200 | -212 | -230 | -232 | Upgrade |
Financing Cash Flow | -17,402 | -2,856 | -10,335 | -10,724 | -7,586 | Upgrade |
Foreign Exchange Rate Adjustments | 129 | 507 | 200 | 180 | -25 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1 | -1 | - | - | -2 | Upgrade |
Net Cash Flow | -13,951 | 17,248 | 5,195 | 14,695 | 458 | Upgrade |
Free Cash Flow | 3,984 | 22,526 | 15,305 | 25,450 | 6,671 | Upgrade |
Free Cash Flow Growth | -82.31% | 47.18% | -39.86% | 281.50% | -57.45% | Upgrade |
Free Cash Flow Margin | 0.35% | 2.33% | 1.69% | 3.33% | 0.64% | Upgrade |
Free Cash Flow Per Share | 43.68 | 241.01 | 162.84 | 266.86 | 69.39 | Upgrade |
Cash Interest Paid | 130 | 173 | 158 | 165 | 278 | Upgrade |
Cash Income Tax Paid | 6,967 | 10,024 | 4,742 | 12,685 | 9,789 | Upgrade |
Levered Free Cash Flow | 3,244 | 26,475 | 13,872 | 21,249 | 3,022 | Upgrade |
Unlevered Free Cash Flow | 3,326 | 26,586 | 13,971 | 21,352 | 3,196 | Upgrade |
Change in Net Working Capital | 16,951 | -6,519 | 4,854 | -5,943 | 19,360 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.